<VariationArchive VariationID="1322829" VariationName="NM_000400.4(ERCC2):c.591_594del (p.Arg196_Tyr197insTer)" VariationType="Deletion" Accession="VCV001322829" Version="6" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-07-29" DateCreated="2015-05-31" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1313126" VariationID="1322829">
      <GeneList>
        <Gene Symbol="ERCC2" FullName="ERCC excision repair 2, TFIIH core complex helicase subunit" GeneID="2068" HGNC_ID="HGNC:3434" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19q13.32</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="45349837" stop="45370573" display_start="45349837" display_stop="45370573" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="45854648" stop="45873844" display_start="45854648" display_stop="45873844" Strand="-" />
          </Location>
          <OMIM>126340</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000400.4(ERCC2):c.591_594del (p.Arg196_Tyr197insTer)</Name>
      <CanonicalSPDI>NC_000019.10:45364837:TGAGT:T</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>19q13.32</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="45364838" stop="45364841" display_start="45364838" display_stop="45364841" variantLength="4" positionVCF="45364837" referenceAlleleVCF="CTGAG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="45868096" stop="45868099" display_start="45868096" display_stop="45868099" variantLength="4" positionVCF="45868095" referenceAlleleVCF="CTGAG" alternateAlleleVCF="C" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.45364839_45364842del" Assembly="GRCh38">
            <Expression>NC_000019.10:g.45364839_45364842del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.45868097_45868100del" Assembly="GRCh37">
            <Expression>NC_000019.9:g.45868097_45868100del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007067.2" sequenceAccession="NG_007067" sequenceVersion="2" change="g.10747_10750del">
            <Expression>NG_007067.2:g.10747_10750del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000400.4" sequenceAccession="NM_000400" sequenceVersion="4" change="c.591_594del" MANESelect="true">
            <Expression>NM_000400.4:c.591_594del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000391.1" sequenceAccession="NP_000391" sequenceVersion="1" change="p.Arg196_Tyr197insTer">
            <Expression>NP_000391.1:p.Arg196_Tyr197insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001130867.2" sequenceAccession="NM_001130867" sequenceVersion="2" change="c.519_522del">
            <Expression>NM_001130867.2:c.519_522del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001124339.1" sequenceAccession="NP_001124339" sequenceVersion="1" change="p.Arg172_Tyr173insTer">
            <Expression>NP_001124339.1:p.Arg172_Tyr173insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_461" sequenceAccession="LRG_461">
            <Expression>LRG_461:g.10747_10750del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_461t1" sequenceAccession="LRG_461t1">
            <Expression>LRG_461t1:c.591_594del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="126340.0004" DB="OMIM" />
        <XRef Type="rs" ID="767747355" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000400.4(ERCC2):c.591_594del (p.Arg196_Tyr197insTer) AND Xeroderma pigmentosum, group D" Accession="RCV002266015" Version="9">
        <ClassifiedConditionList TraitSetID="5504">
          <ClassifiedCondition DB="MedGen" ID="C0268138">Xeroderma pigmentosum, group D</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1997-01-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000400.4(ERCC2):c.591_594del (p.Arg196_Tyr197insTer) AND Cerebrooculofacioskeletal syndrome 2" Accession="RCV003464133" Version="2">
        <ClassifiedConditionList TraitSetID="5505">
          <ClassifiedCondition DB="MedGen" ID="C1853102">Cerebrooculofacioskeletal syndrome 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000400.4(ERCC2):c.591_594del (p.Arg196_Tyr197insTer) AND not provided" Accession="RCV003560844" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-31" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-31" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2015-05-31" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11335038</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19085937</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19934020</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26993158</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9101292</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9238033</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="5504" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="4030" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">XP4 XERODERMA PIGMENTOSUM VIII</ElementValue>
                <XRef Type="MIM" ID="278730" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D</ElementValue>
                <XRef Type="MIM" ID="278730" DB="OMIM" />
                <XRef Type="Allelic variant" ID="126340.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="126340.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="126340.0015" DB="OMIM" />
                <XRef Type="Allelic variant" ID="126340.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="126340.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="126340.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="126340.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="126340.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="126340.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="126340.0012" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Xeroderma pigmentosum, group D</ElementValue>
                <XRef ID="68637004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">XERODERMA PIGMENTOSUM IV</ElementValue>
                <XRef Type="MIM" ID="278730" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">XP, GROUP D</ElementValue>
                <XRef Type="MIM" ID="278730" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">XP, GROUP H</ElementValue>
                <XRef Type="MIM" ID="278730" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">XP8</ElementValue>
                <XRef Type="MIM" ID="278730" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">XPD</ElementValue>
                <XRef Type="MIM" ID="278730" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">XPDC</ElementValue>
                <XRef Type="MIM" ID="278730" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">XPH</ElementValue>
                <XRef Type="MIM" ID="278730" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Xeroderma pigmentosum (XP) is characterized by: Acute sun sensitivity (severe sunburn with blistering, persistent erythema on minimal sun exposure) with marked freckle-like pigmentation of the face before age two years; Sunlight-induced ocular involvement (photophobia, severe keratitis, atrophy of the skin of the lids, ocular surface neoplasms); Greatly increased risk of sunlight-induced cutaneous neoplasms (basal cell carcinoma, squamous cell carcinoma, melanoma) within the first decade of life. Approximately 25% of affected individuals have neurologic manifestations (acquired microcephaly, diminished or absent deep tendon stretch reflexes, progressive sensorineural hearing loss, progressive cognitive impairment, and ataxia). The most common causes of death are skin cancer, neurologic degeneration, and internal cancer. The median age at death in persons with XP with neurodegeneration (29 years) was found to be younger than that in persons with XP without neurodegeneration (37 years).</Attribute>
                <XRef ID="NBK1397" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16452" />
                <XRef ID="16452" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301571</ID>
                <ID Source="BookShelf">NBK1397</ID>
              </Citation>
              <XRef ID="C0268138" DB="MedGen" />
              <XRef ID="MONDO:0010212" DB="MONDO" />
              <XRef Type="MIM" ID="278730" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="5505" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="765" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Cerebrooculofacioskeletal syndrome 2</ElementValue>
                <XRef ID="Cerebrooculofacioskeletal+syndrome+2/7946" DB="Genetic Alliance" />
                <XRef ID="MONDO:0012553" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">COFS2</ElementValue>
                <XRef Type="MIM" ID="610756" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15497" />
                <XRef ID="15497" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C1853102" DB="MedGen" />
              <XRef ID="MONDO:0012553" DB="MONDO" />
              <XRef Type="MIM" ID="610756" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="38550" SubmissionDate="2015-05-29" DateLastUpdated="2022-09-24" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="126340.0004_XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D" title="ERCC2, 4-BP DEL, NT668_XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D" />
        <ClinVarAccession Accession="SCV000038550" DateUpdated="2022-09-24" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1997-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Kobayashi et al. (1997) reported 2 causative mutations of the XPD gene in a Japanese patient with xeroderma pigmentosum complementation group D (XPD; 278730) and only mild skin symptoms of the disorder, without Cockayne syndrome, trichothiodystrophy, or other neurologic complications. One of the mutations in this compound heterozygote was a 4-bp deletion at nucleotides 668 to 671, resulting in frameshift and premature termination. The other was a nucleotide substitution leading to conversion of serine-541 to arginine (S541R; 126340.0005) in helicase domain IV of the XPD protein. The patient's father was heterozygous for the deletion, whereas the mother was heterozygous for the S541R mutation. An expression study showed that the XPD cDNA containing the deletion or the S541R missense mutation failed to restore UV sensitivity of XPD cells, whereas the wildtype XPD cDNA restored it to the normal level.</Attribute>
              <Citation>
                <ID Source="PubMed">9101292</ID>
              </Citation>
              <XRef DB="OMIM" ID="278730" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ERCC2" />
          </GeneList>
          <Name>ERCC2, 4-BP DEL, NT668</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">4-BP DEL, NT668</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="126340.0004" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7983736" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="4957146|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004298416" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9238033</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11335038</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19085937</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19934020</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26993158</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Tyr197*) in the ERCC2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ERCC2 are known to be pathogenic (PMID: 9238033, 11335038, 19085937, 19934020). This variant is present in population databases (rs767747355, gnomAD 0.006%). This premature translational stop signal has been observed in individual(s) with xeroderma pigmentosum, group D (PMID: 26993158). ClinVar contains an entry for this variant (Variation ID: 1322829). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ERCC2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000019.9:g.45868096_45868099del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7842366" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000400.4:c.591_594del|OMIM:610756" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004194625" DateUpdated="2024-06-17" DateCreated="2023-12-30" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000400.4:c.591_594del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="610756" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="38550" TraitType="Disease" MappingType="Name" MappingValue="XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D" MappingRef="Preferred">
        <MedGen CUI="C0268138" Name="Xeroderma pigmentosum, group D" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7983736" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7842366" TraitType="Disease" MappingType="XRef" MappingValue="610756" MappingRef="OMIM">
        <MedGen CUI="C1853102" Name="Cerebrooculofacioskeletal syndrome 2" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="1" DateDeleted="2023-03-03">SCV002022199</Accession>
        <Description>not specified</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

